Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.

Autor: Zhang, Baoyuan1 (AUTHOR), Li, Ning2 (AUTHOR), Gao, Jiaming1 (AUTHOR), Zhao, Yuxi2 (AUTHOR), Jiang, Jun3 (AUTHOR), Xie, Shuang3 (AUTHOR), Zhang, Cuiping4 (AUTHOR), Zhang, Qingyu5 (AUTHOR), Liu, Leo3 (AUTHOR), Wang, Zaiqi3 (AUTHOR), Ji, Dongmei6 (AUTHOR) jid09@fudan.edu.cn, Wu, Lingying2 (AUTHOR) wulingying@csco.org.cn, Ren, Ruibao1,7 (AUTHOR) rbren@sjtu.edu.cn
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 2/19/2024, Vol. 43 Issue 1, p1-21. 21p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje